Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 4Phase 3 4Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Completed 9Terminated 4Unknown 2Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Prostatic Neoplasms 1Osteoporosis 1Melanoma 1Locally Advanced Breast Cancer and Large Operable Breast Cancer 1Leukemia, B-Cell 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Cholecalciferol × Clear all
NCT01608451 2022-05-02

Randomized Controlled Trial of Neo-adjuvant Progesterone and Vitamin D3 in Women With Large Operable Breast Cancer and Locally Advanced Breast Cancer

Tata Memorial Hospital

Phase 3 Terminated
800 enrolled
Breast

Locally Advanced Breast Cancer and Large Operable Breast Cancer

NCT00058188 2020-12-08

Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation

Northwestern University

Phase 3 Terminated
53 enrolled
Genitourinary

Osteoporosis, Prostatic Neoplasms

NCT01518959 2020-07-16

D-HEM

Semmelweis University

Phase 3 Terminated
31 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT01264874 2018-01-31

MelaViD

European Institute of Oncology

Phase 3 Terminated
150 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡